8-K

Company

X4 Pharmaceuticals, Inc

Filed

November 14, 2023

Period of Report

November 13, 2023

Accession Number

0001628280-23-038936

An 8-K is a current report used to announce material events that shareholders should know about — such as earnings releases, mergers, executive changes, or bankruptcy. Learn more about 8-K filings →